Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pronzato

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Annals of the New York Academy of Sciences|November 30, 1993
The role of lonidamine in the treatment of breast cancer patientsR Rosso, G Gardin, P Pronzato, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1991
Tamoxifen and alpha interferon in advanced breast cancerL Miglietta, L Repetto, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancerL Repetto, L Miglietta, G Gardin, et al.
Breast Cancer Research and Treatment|January 1, 1994
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancerG Gardin, A Alama, R Rosso, et al.
Cancer Treatment Reports|December 1, 1987
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancerA Ardizzoni, V Fusco, M Gulisano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approachG Gardin, R Rosso, E Campora, et al.
Breast Cancer Research and Treatment|July 1, 1988
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II studyD Amoroso, P Pronzato, G Bertelli, et al.
Cancer|May 15, 1997
Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task ForceM C Pennucci, A Ardizzoni, P Pronzato, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical resultsP F Conte, G Gardin, P Pronzato, et al.
British Journal of Cancer|February 1, 1989
Phase II study of lonidamine in metastatic breast cancerP Pronzato, D Amoroso, G Bertelli, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Annals of the New York Academy of Sciences|November 30, 1993
The role of lonidamine in the treatment of breast cancer patientsR Rosso, G Gardin, P Pronzato, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1991
Tamoxifen and alpha interferon in advanced breast cancerL Miglietta, L Repetto, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancerL Repetto, L Miglietta, G Gardin, et al.
Breast Cancer Research and Treatment|January 1, 1994
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancerG Gardin, A Alama, R Rosso, et al.
Cancer Treatment Reports|December 1, 1987
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancerA Ardizzoni, V Fusco, M Gulisano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approachG Gardin, R Rosso, E Campora, et al.
Breast Cancer Research and Treatment|July 1, 1988
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II studyD Amoroso, P Pronzato, G Bertelli, et al.
Cancer|May 15, 1997
Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task ForceM C Pennucci, A Ardizzoni, P Pronzato, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical resultsP F Conte, G Gardin, P Pronzato, et al.
British Journal of Cancer|February 1, 1989
Phase II study of lonidamine in metastatic breast cancerP Pronzato, D Amoroso, G Bertelli, et al.
Pageof 13